A functionally biosimilar mRNA prophylactic or therapeutic vaccine, or vaccine booster, to enable sustained immunity to current and future SARS-CoV-2 variants.
The COVID-19 pandemic cost 20 million lives and $28 Trillion dollars. https://normaxbiomed.com/
A functionally biosimilar mRNA prophylactic or therapeutic vaccine, or vaccine booster, to enable sustained immunity to current and future SARS-CoV-2 variants. https://normaxbiomed.com/
UCV-mRNA vaccine design, testing and pre-clinical validation.